JRI News Alert Nuveen Real Asset Income and Gr (JRI) 19.24 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 1:33 AM

Nuveen Real Asset Income and Gr (JRI) 19.24 $JRI

Nuveen Closed-End Funds Declare Monthly Distributions
Business Wire - Mon Feb 02, 4:00PM CST
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that 77 Nuveen closed-end funds declared regular monthly distributions and two closed-end funds declared regular quarterly distributions. These funds represent a broad range of tax-exempt, taxable fixed and floating rate income investment strategies for investors seeking to build sophisticated and diversified long-term investment portfolios for cash flow. The funds' monthly distributions are listed below.
NTC: 12.62 (-0.01), NKG: 12.86 (-0.05), NBD: 21.32 (-0.25), NOM: 16.00 (+0.59), JLS: 23.31 (-0.02), JQC: 9.02 (+0.03), NXC: 15.39 (+0.07), JPI: 23.41 (+0.03), JTP: 8.52 (unch), JHP: 8.62 (-0.02), NKX: 14.57 (-0.06), NBB: 20.93 (-0.16), NSL: 6.56 (+0.03), JPS: 9.26 (+0.03), NAZ: 14.26 (-0.09), JPW: 17.14 (+0.06), NNC: 13.07 (-0.07), NVX: 14.47 (-0.06), JMT: 22.85 (+0.12), JMM: 7.73 (-0.05), NJV: 14.74 (-0.10), NCB: 16.69 (-0.09), NNP: 14.70 (+0.01), NCA: 10.49 (+0.04), NRK: 13.01 (-0.01), NNY: 9.88 (-0.02), NMI: 11.93 (-0.08), NVG: 14.32 (-0.09), NQI: 13.35 (-0.08), JSD: 16.91 (+0.05), NZF: 14.06 (-0.07), NQM: 15.48 (+0.05), NUW: 17.28 (-0.16), NMA: 13.75 (-0.07), NQP: 13.95 (-0.14), NZH: 13.47 (-0.03), NQS: 13.99 (-0.08), JRI: 19.24 (+0.12), JFR: 11.04 (+0.09), NMY: 12.67 (+0.01), NQU: 13.98 (-0.08), NUO: 15.27 (-0.08), NMZ: 13.60 (-0.17), JRO: 11.32 (+0.09), NUV: 9.86 (-0.02), NMO: 13.53 (-0.09), NYV: 15.31 (+0.04), NMS: 15.25 (unch), NMT: 13.23 (-0.07), NUM: 13.77 (-0.13), NEV: 15.46 (unch), NIQ: 12.98 (+0.01), NIO: 14.36 (-0.12), NIM: 10.63 (+0.04), NPI: 13.92 (-0.09), NPF: 13.86 (-0.07), DRA: 17.77 (+0.12), NPM: 14.02 (-0.15), JPC: 9.54 (+0.03), NTX: 14.35 (+0.03), NPP: 14.71 (-0.11), JGH: 17.04 (-0.09), NPN: 15.19 (+0.14), NXJ: 13.63 (unch), NPT: 13.38 (-0.09), NXK: 13.49 (-0.03), NXN: 13.95 (unch), NAD: 14.11 (-0.10), NEA: 13.73 (-0.08), NAC: 15.20 (-0.07), NXP: 14.49 (-0.04), NPV: 13.47 (-0.03), NXQ: 13.81 (-0.14), NXR: 14.58 (-0.08), NAN: 13.72 (unch), NID: 12.84 (-0.02)

Getting The Defense On The Field
Left Banker - at Seeking Alpha - Fri Jan 16, 8:47AM CST

PDI: 29.51 (unch), SPLV: 38.18 (-0.27), ETG: 16.61 (+0.10), VFC: 75.26 (+4.26), VIG: 82.39 (+0.48), WFC: 55.33 (+0.47), JTD: 16.17 (+0.02), TLT: 128.19 (-1.33), T: 34.66 (+0.05), JRI: 19.24 (+0.12), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), UTG: 31.01 (-0.73), OXLC: 15.22 (-0.12), ETY: 11.52 (+0.05), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), USMV: 41.48 (+0.03), AFL: 62.13 (+0.33), RQI: 12.36 (-0.10), SDY: 79.16 (+0.32)

Several Nuveen Closed-End Funds Declare Capital Gains
Business Wire - Tue Dec 16, 4:37PM CST
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that several closed-end funds have declared additional cash distributions with the record, ex-dividend and payable date mentioned below.
JPI: 23.41 (+0.03), JTP: 8.52 (unch), JPW: 17.14 (+0.06), JRI: 19.24 (+0.12), JHP: 8.62 (-0.02), JCE: 17.57 (-0.01), NAD: 14.11 (-0.10), JSD: 16.91 (+0.05), NPP: 14.71 (-0.11), JPS: 9.26 (+0.03)

Update: Double-Digit Distribution Portfolio
Left Banker - at Seeking Alpha - Tue Dec 02, 2:42AM CST

PDI: 29.51 (unch), NFJ: 16.41 (-0.10), PCI: 20.56 (+0.02), IGA: 11.64 (+0.02), DVHL: 24.31 (+0.24), SDRL: 12.32 (-0.70), MORL: 19.93 (+0.09), GGN: 7.59 (+0.12), BQR: 7.57 (+0.01), EOS: 14.19 (+0.11), JRI: 19.24 (+0.12), BIT: 17.66 (-0.01), BOE: 13.57 (+0.08), EDI: 14.88 (+0.18), ETV: 14.67 (-0.01), FFC: 20.73 (+0.06), OXLC: 15.22 (-0.12), EDF: 15.46 (+0.03), HQH: 34.20 (+0.06), STK: 18.72 (+0.07), TYG: 44.58 (+0.21)

Tomorrow's Ex-Dividends To Watch: NHS, JRI, JRO
at The Street - Thu Oct 09, 9:00AM CDT
NHS JRI JRO are going ex-dividend tomorrow, Friday, October 10, 2014
JRI: 19.24 (+0.12), JRO: 11.32 (+0.09), NHS: 12.56 (+0.03)

Nuveen Announces Results of Closed-End Fund Shareholder Meetings
Business Wire - Tue Aug 19, 3:30PM CDT
--Investment Management & Sub-Advisory Agreements Approved
JDD: 12.28 (-0.08), NTC: 12.62 (-0.01), NKG: 12.86 (-0.05), NBD: 21.32 (-0.25), NOM: 16.00 (+0.59), JLS: 23.31 (-0.02), JQC: 9.02 (+0.03), NXC: 15.39 (+0.07), JPI: 23.41 (+0.03), JTP: 8.52 (unch), JHP: 8.62 (-0.02), JPG: 14.35 (+0.06), NBB: 20.93 (-0.16), NKX: 14.57 (-0.06), NSL: 6.56 (+0.03), JPS: 9.26 (+0.03), NAZ: 14.26 (-0.09), JPW: 17.14 (+0.06), NNC: 13.07 (-0.07), NVX: 14.47 (-0.06), JMT: 22.85 (+0.12), NNJ: 13.68 (+0.01), NJV: 14.74 (-0.10), NCB: 16.69 (-0.09), NNP: 14.70 (+0.01), NCA: 10.49 (+0.04), NRK: 13.01 (-0.01), JMF: 19.00 (+0.37), NNY: 9.88 (-0.02), NMI: 11.93 (-0.08), NVG: 14.32 (-0.09), NQI: 13.35 (-0.08), NQJ: 13.30 (+0.01), JSD: 16.91 (+0.05), NZF: 14.06 (-0.07), NUW: 17.28 (-0.16), NMA: 13.75 (-0.07), NQP: 13.95 (-0.14), NZH: 13.47 (-0.03), NQS: 13.99 (-0.08), JRI: 19.24 (+0.12), JFR: 11.04 (+0.09), NMY: 12.67 (+0.01), NQU: 13.98 (-0.08), NUO: 15.27 (-0.08), NMZ: 13.60 (-0.17), JRO: 11.32 (+0.09), NUV: 9.86 (-0.02), JRS: 11.83 (-0.07), NMO: 13.53 (-0.09), NUJ: 13.25 (-0.01), NYV: 15.31 (+0.04), NUM: 13.77 (-0.13), NEV: 15.46 (unch), NXZ: 14.20 (-0.11), NIQ: 12.98 (+0.01), JCE: 17.57 (-0.01), NIO: 14.36 (-0.12), NIM: 10.63 (+0.04), NPI: 13.92 (-0.09), NPF: 13.86 (-0.07), JTA: 13.70 (+0.10), NPM: 14.02 (-0.15), JPC: 9.54 (+0.03), NTX: 14.35 (+0.03), JTD: 16.17 (+0.02), NPP: 14.71 (-0.11), NPN: 15.19 (+0.14), NXJ: 13.63 (unch), NPT: 13.38 (-0.09), NXK: 13.49 (-0.03), JMLP: 16.39 (+0.21), NAD: 14.11 (-0.10), NXN: 13.95 (unch), NEA: 13.73 (-0.08), NAC: 15.20 (-0.07), NXP: 14.49 (-0.04), NPV: 13.47 (-0.03), NXQ: 13.81 (-0.14), NXR: 14.58 (-0.08), NAN: 13.72 (unch), JGV: 12.93 (+0.09), NID: 12.84 (-0.02)

3 Stocks Going Ex-Dividend Tomorrow: NNP, JRI, BLW
at The Street - Tue Aug 12, 9:05AM CDT
NNP JRI BLW are going ex-dividend tomorrow, Wednesday, August 13, 2014
JRI: 19.24 (+0.12), NNP: 14.70 (+0.01), BLW: 15.73 (-0.10)

Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: NUO, JRI, MMD
at The Street - Thu Jul 10, 9:11AM CDT
NUO JRI MMD are going ex-dividend tomorrow, Friday, July 11, 2014, 4:00 AM ET
JRI: 19.24 (+0.12), NUO: 15.27 (-0.08), MMD: 18.40 (-0.08)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Dickinson Brands Celebrates Witch Hazel Legacy with Event

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Angels on Call Sets Benchmark for Specialized Homecare

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

New Chapter Recovery Garners Key Accreditations

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...